Company news
AIML Innovations Inc news in 2026
AIML Innovations Inc's news releases, calls and decks from 2026, newest first.
AI/ML Innovations Inc. Announces Proposed Private Placement
November 5, 2026
AIML Subsidiary NeuralCloud Signs Agreement with Etisense to Advance Animal-Model ECG Labeling with MaxYield(TM)
October 29, 2026
AI/ML Innovations Announces Advance Notice Provisions
October 28, 2026
AI/ML Innovations Announces Completion of Share Issuance
October 13, 2026
AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
October 2, 2026
AIML Subsidiary NeuralCloud Signs Binding Commercial Term Sheet with VetMed Consultants for MaxYield(TM) ECG Services
October 1, 2026
AIML Subsidiary NeuralCloud Enters Strategic Partnership with RKS Medical Technologies to Advance CardioYield(TM) Clinical Pilots
September 29, 2026
AI/ML Innovations Launches Quantum Soma Initiative with Dynex Quantum Technologies for Contactless Quantum Biosensing Platform
September 21, 2026
AI/ML Innovations Inc. Closes Final Tranche of Private Placement
September 14, 2026
AI/ML Innovations subsidiary NeuralCloud Appoints Former FDA Reviewer Dr. Mehmet Kosoglu as the Head of Regulatory Affairs
September 1, 2026
AI/ML Innovations Inc. Closes First Tranche of Private Placement
August 26, 2026
AIML Subsidiary NeuralCloud Signs Term Sheet with Island Mobile Cardiology Testing for CardioYield(TM) Pilot
August 18, 2026
AI/ML Innovations' Subsidiary NeuralCloud Achieves ISO 13485: 2016 (MDSAP) Certification
August 11, 2026
AI/ML Innovations Inc. Announces Grant of U.S. Patent Expanding Protection for AI-Driven ECG Analysis
June 23, 2026
AI/ML Subsidiary NeuralCloud Appoints Cardiac Monitoring Veterans Dale and Nicholas DuBois to Lead Clinical and Overread Operations
June 2, 2026
AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
May 11, 2026
AI/ML Innovations Announces Completion of Share Issuance
April 17, 2026
Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform
March 31, 2026
AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000
March 27, 2026
AIML Subsidiary NeuralCloud Enters Research Services Agreement with Baker Heart and Diabetes Institute to Support AI-Driven ECG Analysis
March 25, 2026
AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
March 12, 2026
Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America
February 24, 2026
AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting
February 12, 2026
Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion
February 10, 2026
AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board
January 28, 2026
AIML Subsidiary NeuralCloud Collaborates with Movesense to Expand Bundled ECG Solutions for Clinical and Wellness Markets
January 20, 2026
AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis
January 8, 2026
AI/ML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale
January 7, 2026